NanoVibronix Subsidiary Awarded New Patent for Device Insertion Tech

The U.S. Patent and Trademark Office has issued a new patent to ENvue Medical Holdings for its medical device insertion guidance system technology. ENvue Medical is a wholly-owned subsidiary of NanoVibronix Inc.

U.S. Patent No. 12,409,105 B2, “Insertion Device Positioning Guidance System and Method” protects the company’s proprietary systems and methods for guiding the insertion of medical devices such as feeding tubes using electromagnetic positioning technology. By improving real-time visualization and accuracy, the invention reduces the risk of misplacement and associated complications, helping clinicians perform procedures with greater safety and efficiency.

“We believe this new patent is a significant milestone for us and highlights the strength of our innovation,” NanoVibronix CEO Doron Besser, M.D., said. “We are continuing to build a robust IP portfolio that not only protects our proprietary technology but also creates strong barriers to entry in our target markets. The issuance of this patent underscores our commitment to advancing solutions that improve patient outcomes while enhancing procedural efficiency. With multiple granted U.S. and international patents, we are confident that ENvue is well-positioned as a leader in next-generation navigation and guidance systems for enteral feeding and other clinical applications. We view this intellectual property as a long-term asset and remain committed to strengthening and expanding our portfolio to protect our competitive advantage and support the company’s growth.”

NanoVibronix Inc. is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. Headquartered in Tyler, Texas, with research and development in Nesher, Israel, the company focuses on two distinct technology platforms:

• Acoustic-based therapeutic technologies, including PainShield and UroShield, which use proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms.
• ENvue Navigation Platform, developed and operated by ENvue Medical, with offices in Arlington Heights, Ill., and Tel Aviv, Israel, is a minimally invasive electromagnetic navigation system intended to help clinicians place feeding tubes into the gastrointestinal tract. Cleared by the U.S. Food and Drug Administration for adult use, ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Future platform expansion may include pediatric and vascular access applications.

NanoVibronix aims to advance standards in non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation across numerous healthcare environments.